APPLICATION
ANDA070625
TYPE
ANDA
ORIGINAL APPROVAL
1986-06-06
LATEST ACTION
1999-05-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
METHYLDOPADiscontinued
METHYLDOPA 500MG · TABLET · ORAL
Approval history
1999-05-12Labeling · Supplement 23AP
1998-06-11Labeling · Supplement 21AP
1996-09-27Labeling · Supplement 20AP
1993-11-16Manufacturing (CMC) · Supplement 17AP
1993-11-16Manufacturing (CMC) · Supplement 15AP
1993-11-16Labeling · Supplement 16AP
1993-08-25Labeling · Supplement 19AP
1993-06-22Labeling · Supplement 18AP
1991-08-07Manufacturing (CMC) · Supplement 12AP
1991-04-04Labeling · Supplement 14AP
1991-01-28Manufacturing (CMC) · Supplement 13AP
1990-06-29Manufacturing (CMC) · Supplement 11AP
1989-08-09Manufacturing (CMC) · Supplement 9AP
1989-05-01Labeling · Supplement 10AP
1989-01-06Manufacturing (CMC) · Supplement 7AP
1988-09-09Labeling · Supplement 4AP
1988-08-26Manufacturing (CMC) · Supplement 6AP
1988-08-10Manufacturing (CMC) · Supplement 5AP
1988-06-13Manufacturing (CMC) · Supplement 2AP
1986-06-06OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.